4 Pharmaceutical Stocks to Buy Now

by Portfolio Grader | June 13, 2014 8:45 am

4 Pharmaceutical Stocks to Buy Now

The grades of four pharmaceutical stocks are on the rise this week on Portfolio Grader[1]. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

NuPathe Inc. (PATH[2]) is making progress this week as its rating of C (“hold”) from last week increases to a B (“buy”) rating this week. NuPathe develops pharmaceutical products used for the treatment and management of neurological and psychiatric diseases. In Portfolio Grader’s specific subcategories of Earnings Momentum and Earnings Revisions, PATH also gets A’s. For more information, get Portfolio Grader’s complete analysis of PATH stock[3].

This week, Watson Pharmaceuticals (WPI[4]) is showing good progress as the company’s rating jumps from a B (“buy”) last week to an A (“strong buy”). Watson develops, manufactures, markets, sells and distributes pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of WPI stock[5].

The rating of Impax Laboratories, Inc. (IPXL[6]) moves up this week, rising from a C to a B. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPXL stock[7].

Mylan (MYL[8]) gets a higher grade this week, advancing from a B last week to an A. Mylan is a global generic and specialty pharmaceuticals company. For more information, get Portfolio Grader’s complete analysis of MYL stock[9].

Louis Navellier’s proprietary Portfolio Grader[10] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[11].

Endnotes:
  1. Portfolio Grader: http://navelliergrowth.investorplace.com/portfolio-grader/
  2. PATH: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=PATH
  3. For more information, get Portfolio Grader’s complete analysis of PATH stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=PATH
  4. WPI: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=WPI
  5. For more information, get Portfolio Grader’s complete analysis of WPI stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=WPI
  6. IPXL: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=IPXL
  7. For more information, get Portfolio Grader’s complete analysis of IPXL stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=IPXL
  8. MYL: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=MYL
  9. For more information, get Portfolio Grader’s complete analysis of MYL stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=MYL
  10. Portfolio Grader: http://navelliergrowth.investorplace.com/portfolio-grader/
  11. here: http://navelliergrowth.investorplace.com/portfolio-grader/

Source URL: http://investorplace.com/2014/06/4-pharmaceutical-stocks-to-buy-now-path-wpi-ipxl-6/
Short URL: http://invstplc.com/1p0Yd8L